Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000167

Chairperson & CEO sold 9,500 shares at an average $543.32 ($5,161,576)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-19 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-19 Sale : show line 2 in the form 10b5-1 −160 $534.75 $85,560 333,783 I
2026-10-19 Sale : show line 3 in the form 10b5-1 −360 $536.36 $193,088 333,423 I
2026-10-19 Sale : show line 4 in the form 10b5-1 −240 $537.11 $128,907 333,183 I
2026-10-19 Sale : show line 5 in the form 10b5-1 −160 $538.54 $86,167 333,023 I
2026-10-19 Sale : show line 6 in the form 10b5-1 −880 $539.79 $475,012 332,143 I
2026-10-19 Sale : show line 7 in the form 10b5-1 −1,800 $540.63 $973,133 330,343 I
2026-10-19 Sale : show line 8 in the form 10b5-1 −520 $541.38 $281,516 329,823 I
Open-market sales · 9,500 sh · avg $543.32 · $5,161,576

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-19 Exercise or conversion : show line 21 in the form 10b5-1 Stock Option −9,500 204,910 I
Loading xslF345X06/primarydocument.xml…